Group 1 - The core point of the news is that Steady Medical has experienced a decline in stock price, dropping 5.07% to 36.15 CNY per share, with a total market value of 21.051 billion CNY [1] - Steady Medical's stock has fallen for three consecutive days, with a cumulative decline of 4.15% during this period [1] - The company, established on August 24, 2000, specializes in the research, production, and sales of cotton products, with its main revenue sources including wet and dry cotton towels (19.87%), surgical consumables (18.15%), traditional wound care products (13.88%), and sanitary napkins (13.02%) [1] Group 2 - From the perspective of fund holdings, one fund under Fuan Da has Steady Medical as a top ten holding, with 12,500 shares held, representing 0.97% of the fund's net value [2] - The fund, Fuan Da Steady Allocation 6-Month Holding Period Mixed Fund (015047), has reported a year-to-date return of 0.57% and a one-year return of 7.06% [2] - The fund manager, Zhao Hengyi, has a tenure of over 14 years, with the best fund return during his management being 44.66% [2]

Core Viewpoint - The stock of Wanjian Medical has experienced fluctuations, with a recent decline of 2.03%, and the company shows a mixed performance in terms of stock price changes over different time frames [1]. Company Overview - Wanjian Medical, established on August 24, 2000, and listed on September 17, 2020, is located in Longhua District, Shenzhen, Guangdong Province. The company specializes in the research, production, and sales of cotton products [1]. - The main revenue sources for Wanjian Medical include: - Consumer products - wet and dry cotton towels (19.87%) - Medical consumables - operating room consumables (18.15%) - Medical consumables - traditional wound care and dressing products (13.88%) - Consumer products - sanitary napkins (13.02%) - Consumer products - adult apparel (12.73%) - Consumer products - infant and children's apparel and supplies (11.36%) - Other spun products (5.24%) - Other non-woven products (4.88%) - Other (supplementary) (0.87%) [1]. Financial Performance - For the period from January to September 2025, Wanjian Medical achieved a revenue of 7.897 billion yuan, reflecting a year-on-year growth of 30.10%. The net profit attributable to the parent company was 732 million yuan, with a year-on-year increase of 32.36% [2]. - Since its A-share listing, Wanjian Medical has distributed a total of 2.875 billion yuan in dividends, with 1.729 billion yuan distributed over the past three years [3]. Shareholder Information - As of September 30, 2025, Wanjian Medical had 32,100 shareholders, an increase of 15.06% from the previous period. The average circulating shares per person rose to 18,048 shares, up by 186.92% [2]. - The top shareholders include: - Huabao Zhongzheng Medical ETF (512170) - 6.5935 million shares, decreased by 841,200 shares - Hong Kong Central Clearing Limited - 4.8997 million shares, increased by 823,000 shares - E Fund Growth Enterprise Board ETF (159915) - 3.8804 million shares, decreased by 656,700 shares [3].

Core Viewpoint - The stock of Steady Medical has experienced fluctuations, with a current price of 40.09 CNY per share and a market capitalization of 23.346 billion CNY, reflecting a year-to-date decline of 3.12% [1] Company Overview - Steady Medical, established on August 24, 2000, and listed on September 17, 2020, is located in Longhua District, Shenzhen, Guangdong Province. The company specializes in the research, production, and sales of cotton products [1] - The main revenue sources include consumer products such as wet and dry cotton towels (19.87%), medical consumables like surgical room products (18.15%), and traditional wound care products (13.88%) [1] Financial Performance - For the period from January to September 2025, Steady Medical reported a revenue of 7.897 billion CNY, marking a year-on-year growth of 30.10%. The net profit attributable to shareholders was 732 million CNY, reflecting a 32.36% increase compared to the previous year [2] - Since its A-share listing, the company has distributed a total of 2.875 billion CNY in dividends, with 1.729 billion CNY paid out in the last three years [3] Shareholder Information - As of September 30, 2025, the number of shareholders increased by 15.06% to 32,100, with an average of 18,048 shares held per shareholder, up by 186.92% [2] - The top shareholders include Huabao Zhongzheng Medical ETF, holding 6.5935 million shares, and Hong Kong Central Clearing Limited, holding 4.8997 million shares, with notable changes in their holdings compared to the previous period [3]

Core Viewpoint - The stock of Steady Medical has shown a positive trend recently, with a notable increase in trading volume and a significant rise in stock price over the past few weeks, indicating investor interest and confidence in the company's performance [1][2]. Company Overview - Steady Medical, established on August 24, 2000, and listed on September 17, 2020, is located in Longhua District, Shenzhen, Guangdong Province. The company specializes in the research, production, and sales of cotton products [1]. - The main revenue sources for Steady Medical include consumer products such as wet and dry cotton towels (19.87%), medical consumables like surgical room products (18.15%), and traditional wound care products (13.88%) [1]. Financial Performance - For the period from January to September 2025, Steady Medical reported a revenue of 7.897 billion yuan, reflecting a year-on-year growth of 30.10%. The net profit attributable to shareholders was 732 million yuan, marking a 32.36% increase compared to the previous year [2]. - Since its A-share listing, Steady Medical has distributed a total of 2.875 billion yuan in dividends, with 1.729 billion yuan paid out in the last three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders for Steady Medical reached 32,100, an increase of 15.06% from the previous period. The average number of circulating shares per person rose to 18,048, up by 186.92% [2]. - The top shareholders include Huabao Zhongzheng Medical ETF, holding 6.5935 million shares, and Hong Kong Central Clearing Limited, with 4.8997 million shares, showing changes in their holdings compared to the previous period [3].

Core Viewpoint - The financial report of Shengjian Medical for the first three quarters of 2025 shows significant growth in revenue and profit, indicating a strong performance in the healthcare and consumer goods sectors [1][2]. Financial Performance - The company's revenue for the first three quarters reached 7.897 billion yuan, a year-on-year increase of 30.10% [1]. - The net profit attributable to shareholders was 732 million yuan, up 32.36% year-on-year [1]. - The net profit excluding non-recurring items was 679 million yuan, reflecting a 43.93% increase year-on-year [1]. - Basic earnings per share stood at 1.26 yuan [1]. Profitability Metrics - The gross margin for the first three quarters was 48.32%, an increase of 0.18 percentage points year-on-year [2]. - The net profit margin was 9.81%, up 0.15 percentage points compared to the same period last year [2]. - In Q3 2025, the gross margin was 48.29%, showing a year-on-year increase of 1.29 percentage points [2]. - The net profit margin for Q3 was 9.87%, up 1.03 percentage points year-on-year [2]. Expense Analysis - Total operating expenses for Q3 amounted to 2.816 billion yuan, an increase of 586 million yuan year-on-year [2]. - The expense ratio was 35.66%, a decrease of 1.08 percentage points from the previous year [2]. - Sales expenses increased by 18.76%, management expenses rose by 40.12%, R&D expenses grew by 25.67%, and financial expenses surged by 95.52% year-on-year [2]. Shareholder Information - As of the end of Q3 2025, the total number of shareholders was 32,100, an increase of 4,203 or 15.06% from the end of the previous half [2]. - The average market value per shareholder decreased from 857,400 yuan to 694,400 yuan, a decline of 19.01% [2]. Company Overview - Shengjian Medical, established on August 24, 2000, and listed on September 17, 2020, is located in Longhua District, Shenzhen, Guangdong Province [3]. - The company specializes in the research, production, and sales of cotton products, with a revenue composition that includes various consumer and medical products [3]. - The company operates in the beauty and personal care sector, specifically in the life paper category, and is involved in multiple concept sectors including medical consumables and elderly care [3].

Core Insights - The company,稳健医疗, closed at 41.24 yuan on July 28, with a decline of 2.92%, and a rolling PE ratio of 31.54 times, resulting in a total market capitalization of 24.015 billion yuan [1][2] - The company ranks 12th in the beauty and personal care industry, which has an average PE ratio of 41.75 times and a median of 44.75 times [1][2] - As of the first quarter of 2025, 29 institutions held shares in the company, with a total of 14.0551 million shares valued at 578 million yuan [1] Company Overview - The main business of the company is the research, production, and sales of cotton-based products, including high-end wound dressings, traditional wound care products, surgical consumables, infection protection products, health personal care products, cotton towels, cotton sanitary napkins, cotton wet wipes, non-woven consumer products, baby products, children's clothing, adult clothing, and textile consumer goods [1] - The company has consistently ranked among the top three exporters of medical dressings in China for several years [1] - The company's "winner" brand has entered over 2,000 hospitals and nearly 40,000 pharmacies in China, with most hospitals being tertiary hospitals, and has product counters in well-known pharmacy chains such as Haiwangxingchen and Laobaixing Pharmacy [1] Financial Performance - In the first quarter of 2025, the company achieved an operating income of 2.605 billion yuan, a year-on-year increase of 36.47%, and a net profit of 249 million yuan, also reflecting a year-on-year increase of 36.26%, with a gross profit margin of 48.46% [2] - The company's PE (TTM) is 31.54, while the industry average is 41.75 and the industry median is 44.75 [2]

正式报名：首届全球心血管大会 | 赠送纸质白皮书 合作伙伴征集：2025全球手术机器人大会 2025年4月29日， 稳健医疗 发布2024年年报。 # 财务数据 # 关 于 稳健医疗 稳健医疗用品股份有限公司成立于 2000 年 8 月 24 日，总部位于广东省深圳市龙华区，2020 年 9 月 17 日在 A 股上市。公司通过 "winner 稳健医疗" 和 "Purcotton 全棉时代" 两大品牌 营收与利润 ： 2024 年实现营业收入 89.78 亿 元，同比增长 9.69% ；归母净利润 6.95 亿 元，同比增长 19.81%；扣非净利润同比大增 43.40%。 单季度数据 ： 2024 年第四季度营业总收入 29.08 亿 元，同比增长 33.72% ， 环比增长 42.78%；归母净 利润 1.42 亿元，同比增长 109.09%，环比下降 15.64%；扣非净利润 2.24 亿元，同比增长 207.02%，环 比增长 54.26%。 盈利能力 ： 2024 年毛利率 47.32% ，同比下降 1.68 个百分点； 净利率 8.25%，较上年同期上升 0.57 个 百分点。从单季度指标来看， ...